TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 29)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
1.5 YEARS CONSIDERED
1.6 CURRENCY CONSIDERED
1.7 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 33)
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Primary sources
2.2.2.2 Key industry insights
2.2.2.3 Breakdown of primaries
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
2.3.1.2 Approach 2: Customer-based market estimation
2.3.1.3 Approach 3: Top-down approach
2.3.1.4 Approach 4: Primary interviews
2.4 DATA TRIANGULATION & MARKET BREAKDOWN
2.5 MARKET SHARE ASSESSMENT
2.6 STUDY ASSUMPTIONS
2.7 ASSUMPTIONS
2.8 RISK ASSESSMENT
2.9 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 50)
4 PREMIUM INSIGHTS (Page No. - 54)
4.1 INTRACARDIAC ECHOCARDIOGRAPHY MARKET OVERVIEW
4.2 INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY REGION, 2024 VS. 2029 (USD MILLION)
4.3 INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY REGION AND END USER, 2023 (USD MILLION)
4.4 GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW (Page No. - 58)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Emergence of predictive analytics in ICE technology
5.2.1.2 Expanding clinical use cases of ICE technology
5.2.1.3 Ongoing integration of ICE technology with other imaging modalities
5.2.1.4 Rising prevalence of cardiac disorders
5.2.2 RESTRAINTS
5.2.2.1 Premium product pricing
5.2.2.2 Dearth of healthcare professionals
5.2.3 OPPORTUNITIES
5.2.3.1 Broadening clinical applications of ICE in structural heart disease interventions
5.2.3.2 Advances in 3D and real-time 3D (4D) imaging
5.2.4 CHALLENGES
5.2.4.1 Technical limitations
5.2.4.2 Increased pricing pressure on market players
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 REGULATORY ANALYSIS
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.2 KEY REGULATORY GUIDELINES
5.4.2.1 North America
5.4.2.1.1 US
5.4.2.1.2 Canada
5.4.2.2 Europe
5.4.2.3 Asia Pacific
5.4.2.3.1 Japan
5.4.2.3.2 India
5.4.2.3.3 China
5.5 REIMBURSEMENT SCENARIO
5.6 ECOSYSTEM ANALYSIS
5.7 INVESTMENT & FUNDING SCENARIO
5.8 TECHNOLOGY ANALYSIS
5.8.1 KEY TECHNOLOGIES
5.8.1.1 Phased-array ICE
5.8.1.2 Rotational ICE
5.8.1.3 Doppler imaging
5.8.1.4 3D ICE technology
5.8.2 COMPLEMENTARY TECHNOLOGIES
5.8.2.1 Intravascular ultrasound (IVUS)
5.8.2.2 Value-added software (AI and IoT)
5.8.2.3 Clinical decision support systems
5.8.2.4 Electrophysiology (EP) mapping systems
5.8.3 ADJACENT TECHNOLOGIES
5.8.3.1 Event monitors
5.8.3.2 Holter monitors
5.9 VALUE CHAIN ANALYSIS
5.9.1 RESEARCH & DEVELOPMENT
5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.9.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
5.10 SUPPLY CHAIN ANALYSIS
5.10.1 PROMINENT COMPANIES
5.10.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.10.3 END USERS
5.11 PRICING ANALYSIS
5.12 PATENT ANALYSIS
5.13 TRADE ANALYSIS
5.14 KEY CONFERENCES & EVENTS, 2024–2025
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.16 KEY STAKEHOLDERS & BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 BUYING CRITERIA
5.17 ADJACENT MARKET ANALYSIS
5.18 UNMET NEEDS & KEY PAIN POINTS
5.19 ARTIFICIAL INTELLIGENCE IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE)
6 INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT (Page No. - 99)
6.1 INTRODUCTION
6.2 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE
6.2.1 2D ULTRASOUND SYSTEMS
6.2.1.1 Increasing integration of modern ICE systems with other diagnostic systems to drive market growth
6.2.2 3D/4D ULTRASOUND SYSTEMS
6.2.2.1 Increasing incidence of cardiovascular diseases worldwide to drive growth
6.2.3 DOPPLER ULTRASOUND SYSTEMS
6.2.3.1 Higher resolution imaging and advanced Doppler techniques to enhance capability of ICE systems
6.3 ICE CATHETERS
6.3.1 DOPPLER ICE CATHETERS
6.3.1.1 Growing preference for minimally invasive cardiac procedures to support market growth
6.3.2 PHASED-ARRAY ICE CATHETERS
6.3.2.1 High cost and limited applications to restrict market growth
6.3.3 FIXED-ARRAY ICE CATHETERS
6.3.3.1 High demand for advanced cardiac imaging solutions to drive innovation and adoption of fixed-array catheters
6.3.4 MECHANICAL ROTATIONAL ICE CATHETERS
6.3.4.1 Innovations in catheter technology to boost market growth
6.4 ICE CONSOLES
6.4.1 CART/TROLLEY-BASED CONSOLES
6.4.1.1 Rising geriatric population to fuel market growth
6.4.2 HANDHELD/PORTABLE CONSOLES
6.4.2.1 Increasing adoption of portable consoles in healthcare facilities to drive market growth
6.5 GUIDING CATHETERS & SHEATHS
6.5.1 INCREASING INTEGRATION OF GUIDING CATHETERS & SHEATHS WITH PORTABLE ICE CONSOLES TO PROPEL MARKET GROWTH
6.6 DISPOSABLE ACCESSORIES
6.6.1 COST OF DISPOSABLE ACCESSORIES TO PLAY SIGNIFICANT ROLE IN DRIVING MARKET GROWTH
6.7 SOFTWARE
6.7.1 INCREASING ADOPTION OF PREDICTIVE ANALYTICS FOR REAL-TIME IMAGING TO BOOST MARKET
7 INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY APPLICATION (Page No. - 114)
7.1 INTRODUCTION
7.2 STRUCTURAL HEART DEFECTS
7.2.1 MITRAL VALVE REPAIR/REPLACEMENT
7.2.1.1 Growing burden of cardiovascular diseases to drive market
7.2.2 AORTIC VALVE REPLACEMENT
7.2.2.1 Growing demand for effective imaging tools like ICE to boost market
7.2.3 OTHER STRUCTURAL HEART DEFECTS
7.3 ELECTROPHYSIOLOGY
7.3.1 GROWING INTEGRATION OF ICE WITH MAPPING SYSTEMS TO DRIVE MARKET GROWTH
7.4 LEFT ATRIAL APPENDAGE CLOSURE
7.4.1 BENEFITS SUCH AS MINIMIZATION OF RADIATION EXPOSURE IN PROCEDURES LIKE LAA CLOSURE TO SUPPORT GROWTH
7.5 CARDIAC MONITORING
7.5.1 BETTER CLINICAL DECISION-MAKING AND IMPROVED PATIENT OUTCOMES TO SUPPORT SEGMENT GROWTH
7.6 OTHER APPLICATIONS
8 INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY END USER (Page No. - 124)
8.1 INTRODUCTION
8.2 HOSPITALS & SURGICAL CENTERS
8.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF ICE TECHNOLOGIES TO BOOST MARKET
8.3 AMBULATORY SURGICAL CENTERS
8.3.1 COST-EFFECTIVENESS AND CONVENIENCE OF AMBULATORY SURGICAL CENTERS TO DRIVE GROWTH
8.4 HOSPITAL-BASED CATH LABS/HYBRID OR INTERVENTIONAL CENTERS
8.4.1 GROWING USE OF ICE IN CATH LABS FOR MINIMALLY INVASIVE CARDIAC PROCEDURES TO BOOST MARKET
8.5 INDEPENDENT DIAGNOSTIC CENTERS
8.5.1 SPECIALIZED EXPERTISE AND ADVANCED ICE TECHNOLOGY IN INDEPENDENT DIAGNOSTIC CENTERS TO BOOST GROWTH
8.6 OTHER END USERS
9 INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY REGION (Page No. - 131)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 Growing number of FDA approvals for ICE devices to support market growth
9.2.2 CANADA
9.2.2.1 Growing public-private funding for research to drive market growth
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
9.3.2 UK
9.3.2.1 Increasing public & private investments to contribute to market growth
9.3.3 FRANCE
9.3.3.1 Statutory health insurance system to support market growth
9.3.4 ITALY
9.3.4.1 Rising incidence of cardiac diseases to drive adoption of ICE devices
9.3.5 SPAIN
9.3.5.1 Growing number of surgical procedures to drive market growth in Spain
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth
9.4.2 CHINA
9.4.2.1 Growing focus of local and international market players to favor market growth
9.4.3 INDIA
9.4.3.1 Increasing government-implemented healthcare initiatives to support market growth
9.4.4 AUSTRALIA
9.4.4.1 R&D tax incentive program to support market growth
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives to drive market growth
9.4.6 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 BRAZIL
9.5.1.1 Brazil to dominate LATAM market
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
9.5.3 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 GCC COUNTRIES
9.6.1.1 Developments in healthcare infrastructure and high government expenditure to drive market
9.6.2 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE (Page No. - 198)
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY
10.3 REVENUE ANALYSIS
10.4 MARKET SHARE ANALYSIS
10.4.1 INTRACARDIAC ECHOCARDIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 Company footprint
10.5.5.2 Product footprint
10.5.5.3 Application footprint
10.5.5.4 End-user footprint
10.5.5.5 Region footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
10.7 COMPANY VALUATION AND FINANCIAL METRICS
10.8 PRODUCT/BRAND COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES AND APPROVALS
10.9.2 DEALS
11 COMPANY PROFILES (Page No. - 219)
11.1 KEY PLAYERS
11.1.1 MEDTRONIC
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product approvals
11.1.1.3.2 Deals
11.1.1.4 MnM view
11.1.1.4.1 Key strengths
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses and competitive threats
11.1.2 ABBOTT
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches and approvals
11.1.2.3.2 Deals
11.1.2.4 MnM view
11.1.2.4.1 Key strengths
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses and competitive threats
11.1.3 SIEMENS HEALTHINEERS AG
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product launches and approvals
11.1.3.4 MnM view
11.1.3.4.1 Key strengths
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses and competitive threats
11.1.4 GE HEALTHCARE
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product approvals
11.1.4.3.2 Deals
11.1.4.4 MnM view
11.1.4.4.1 Key strengths
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses and competitive threats
11.1.5 BOSTON SCIENTIFIC CORPORATION
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Product launches
11.1.5.3.2 Deals
11.1.5.3.3 Expansions
11.1.5.4 MnM view
11.1.5.4.1 Key strengths
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses and competitive threats
11.1.6 PHILIPS HEALTHCARE
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Product launches and approvals
11.1.6.3.2 Deals
11.1.6.3.3 Expansions
11.1.6.4 MnM view
11.1.6.4.1 Key strengths
11.1.6.4.2 Strategic choices
11.1.6.4.3 Weaknesses and competitive threats
11.1.7 JOHNSON & JOHNSON MEDTECH
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Product launches and approvals
11.1.7.3.2 Deals
11.1.7.4 MnM view
11.1.7.4.1 Key strengths
11.1.7.4.2 Strategic choices
11.1.7.4.3 Weaknesses and competitive threats
11.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.8.3 Recent developments
11.1.8.3.1 Product launches
11.1.8.3.2 Deals
11.1.9 EDWARDS LIFESCIENCES CORPORATION
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 CANON MEDICAL SYSTEMS CORPORATION
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.10.3 Recent developments
11.1.10.3.1 Product launches
11.1.10.3.2 Deals
11.1.11 FUJIFILM HOLDINGS CORPORATION
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.11.3 Recent developments
11.1.11.3.1 Product launches
11.1.11.3.2 Deals
11.1.12 GUERBET
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.12.3 Recent developments
11.1.12.3.1 Deals
11.1.13 TERUMO CORPORATION
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.13.3 Recent developments
11.1.13.3.1 Deals
11.1.14 LIVANOVA
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.15 INFRAREDX INC.
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.16 STEREOTAXIS, INC.
11.1.16.1 Business overview
11.1.16.2 Products offered
11.1.16.3 Recent developments
11.1.16.3.1 Deals
11.1.17 B. BRAUN SE
11.1.17.1 Business overview
11.1.17.2 Products offered
11.1.18 ESAOTE SPA
11.1.18.1 Business overview
11.1.18.2 Products offered
11.1.18.3 Recent developments
11.1.18.3.1 Product launches
11.2 OTHER PLAYERS
11.2.1 CHISON MEDICAL TECHNOLOGIES CO., LTD.
11.2.2 SHIFAMED, LLC
11.2.3 CONAVI MEDICAL INC.
11.2.4 XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD.
11.2.5 BK MEDICAL
11.2.6 BENQ MEDICAL TECHNOLOGY
11.2.7 ECHONOUS INC.
11.2.8 VOLTA MEDICAL
11.2.9 TRIVITRON HEALTHCARE
11.2.10 ECHOPIXEL
11.2.11 CATHVISION
11.2.12 PIE MEDICAL IMAGING BV
12 APPENDIX (Page No. - 288)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES (261 TABLES)
TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
TABLE 2 STUDIES ON AI IN ECHOCARDIOGRAPHIC DIAGNOSTICS
TABLE 3 INTRACARDIAC ECHOCARDIOGRAPHY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 US: CLASSIFICATION OF MEDICAL EQUIPMENT
TABLE 10 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 11 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 12 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 14 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
TABLE 15 AVERAGE SELLING PRICE OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY REGION, 2023
TABLE 16 IMPORT DATA FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES (HS CODE 901819), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 17 EXPORT DATA FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES (HS CODE 901819), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 18 INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY: DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2024–2025
TABLE 19 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
TABLE 21 INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY: UNMET CUSTOMER NEEDS & KEY PAIN POINTS
TABLE 22 INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 23 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 24 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 25 2D ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 26 3D/4D ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 27 DOPPLER ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 29 ICE CATHETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 30 DOPPLER ICE CATHETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 31 PHASED-ARRAY ICE CATHETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 32 FIXED-ARRAY ICE CATHETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 33 MECHANICAL ROTATIONAL ICE CATHETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 34 ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 35 ICE CONSOLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 36 CART/TROLLEY-BASED CONSOLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 37 HANDHELD/PORTABLE CONSOLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 38 GUIDING CATHETERS & SHEATHS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 39 ICE DISPOSABLE ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 40 ICE SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 41 INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 42 INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 43 MARKET FOR STRUCTURAL HEART DEFECTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 44 MARKET FOR MITRAL VALVE REPAIR/REPLACEMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 45 MARKET FOR AORTIC VALVE REPLACEMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 MARKET FOR OTHER STRUCTURAL HEART DEFECTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 47 MARKET FOR ELECTROPHYSIOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 48 MARKET FOR LEFT ATRIAL APPENDAGE CLOSURE, BY REGION, 2022–2029 (USD MILLION)
TABLE 49 MARKET FOR CARDIAC MONITORING, BY REGION, 2022–2029 (USD MILLION)
TABLE 50 MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 52 MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 53 MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 54 MARKET FOR HOSPITAL-BASED CATH LABS/HYBRID OR INTERVENTIONAL CENTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 55 MARKET FOR INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 56 MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 57 INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
TABLE 58 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 60 NORTH AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 61 NORTH AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 62 NORTH AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 63 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 64 NORTH AMERICA: MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 66 US: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 67 US: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 68 US: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 69 US: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 70 CANADA: RESEARCH GRANTS IN INTRACARDIAC ECHOCARDIOGRAPHY
TABLE 71 CANADA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 72 CANADA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 73 CANADA: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 74 CANADA: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 75 EUROPE: PRODUCT APPROVALS IN INTRACARDIAC ECHOCARDIOGRAPHY
TABLE 76 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 EUROPE: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 78 EUROPE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 79 EUROPE: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 80 EUROPE: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 81 EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 82 EUROPE: MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 84 GERMANY: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 85 GERMANY: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 86 GERMANY: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 87 GERMANY: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 88 UK: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 89 UK: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 90 UK: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 UK: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 92 FRANCE: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 93 FRANCE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 94 FRANCE: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 95 FRANCE: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 96 ITALY: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 97 ITALY: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 98 ITALY: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 99 ITALY: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 100 SPAIN: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 101 SPAIN: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 102 SPAIN: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 103 SPAIN: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 104 REST OF EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 105 REST OF EUROPE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 106 REST OF EUROPE: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 107 REST OF EUROPE: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 108 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 ASIA PACIFIC: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 110 ASIA PACIFIC: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 111 ASIA PACIFIC: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 112 ASIA PACIFIC: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 114 ASIA PACIFIC: MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 115 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 116 JAPAN: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY
TABLE 117 JAPAN: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 118 JAPAN: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 119 JAPAN: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 120 JAPAN: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 121 CHINA: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY
TABLE 122 CHINA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 123 CHINA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 124 CHINA: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 125 CHINA: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 126 INDIA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 127 INDIA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 128 INDIA: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 129 INDIA: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 130 AUSTRALIA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 131 AUSTRALIA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 132 AUSTRALIA: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 133 AUSTRALIA: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 134 SOUTH KOREA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 135 SOUTH KOREA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 136 SOUTH KOREA: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 137 SOUTH KOREA: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 REST OF ASIA PACIFIC: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY MARKET
TABLE 139 REST OF ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 140 REST OF ASIA PACIFIC: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 142 REST OF ASIA PACIFIC: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 143 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 145 LATIN AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 146 LATIN AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 148 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 149 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 151 BRAZIL: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 152 BRAZIL: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 153 BRAZIL: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 BRAZIL: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 155 MEXICO: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 156 MEXICO: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 157 MEXICO: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 158 MEXICO: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 REST OF LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 160 REST OF LATIN AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 161 REST OF LATIN AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 162 REST OF LATIN AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 163 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 164 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 165 MIDDLE EAST & AFRICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 171 GCC COUNTRIES: INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 172 GCC COUNTRIES: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 173 GCC COUNTRIES: ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 174 GCC COUNTRIES: ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 175 REST OF MIDDLE EAST & AFRICA (ROMEA): INTRACARDIAC ECHOCARDIOGRAPHY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 176 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 177 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 178 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE CONSOLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 179 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN INTRACARDIAC ECHOCARDIOGRAPHY MARKET
TABLE 180 INTRACARDIAC ECHOCARDIOGRAPHY MARKET: DEGREE OF COMPETITION
TABLE 181 MARKET: PRODUCT FOOTPRINT
TABLE 182 MARKET: APPLICATION FOOTPRINT
TABLE 183 MARKET: END-USER FOOTPRINT
TABLE 184 MARKET: REGION FOOTPRINT
TABLE 185 MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 186 MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 187 MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JUNE 2024
TABLE 188 MARKET: DEALS, JANUARY 2021–JUNE 2024
TABLE 189 MEDTRONIC: COMPANY OVERVIEW
TABLE 190 MEDTRONIC: PRODUCTS OFFERED
TABLE 191 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2020–JUNE 2024
TABLE 192 MEDTRONIC: DEALS, JANUARY 2020–JUNE 2024
TABLE 193 ABBOTT: COMPANY OVERVIEW
TABLE 194 ABBOTT: PRODUCTS OFFERED
TABLE 195 ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020–JUNE 2024
TABLE 196 ABBOTT: DEALS, JANUARY 2020–JUNE 2024
TABLE 197 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 198 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
TABLE 199 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020–JUNE 2024
TABLE 200 GE HEALTHCARE: COMPANY OVERVIEW
TABLE 201 GE HEALTHCARE: PRODUCTS OFFERED
TABLE 202 GE HEALTHCARE: PRODUCT APPROVALS, JANUARY 2020–JUNE 2024
TABLE 203 GE HEALTHCARE: DEALS, JANUARY 2020–JUNE 2024
TABLE 204 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 205 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 206 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2024
TABLE 207 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2020–JUNE 2024
TABLE 208 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2020–JUNE 2024
TABLE 209 PHILIPS HEALTHCARE: COMPANY OVERVIEW
TABLE 210 PHILIPS HEALTHCARE: PRODUCTS OFFERED
TABLE 211 PHILIPS HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020–JUNE 2024
TABLE 212 PHILIPS HEALTHCARE: DEALS, JANUARY 2020–JUNE 2024
TABLE 213 PHILIPS HEALTHCARE: EXPANSIONS, JANUARY 2020–JUNE 2024
TABLE 214 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
TABLE 215 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
TABLE 216 JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020–JUNE 2024
TABLE 217 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2020–JUNE 2024
TABLE 218 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
TABLE 219 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
TABLE 220 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2024
TABLE 221 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: DEALS, JANUARY 2020–JUNE 2024
TABLE 222 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
TABLE 223 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
TABLE 224 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 225 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED
TABLE 226 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2024
TABLE 227 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2020–JUNE 2024
TABLE 228 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 229 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 230 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2024
TABLE 231 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2020–JUNE 2024
TABLE 232 GUERBET: COMPANY OVERVIEW
TABLE 233 GUERBET: PRODUCTS OFFERED
TABLE 234 GUERBET: DEALS, JANUARY 2020–JUNE 2024
TABLE 235 TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 236 TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 237 TERUMO CORPORATION: DEALS, JANUARY 2020–JUNE 2024
TABLE 238 LIVANOVA: COMPANY OVERVIEW
TABLE 239 LIVANOVA: PRODUCTS OFFERED
TABLE 240 INFRAREDX INC.: COMPANY OVERVIEW
TABLE 241 INFRAREDX INC.: PRODUCTS OFFERED
TABLE 242 STEREOTAXIS, INC.: COMPANY OVERVIEW
TABLE 243 STEREOTAXIS, INC.: PRODUCTS OFFERED
TABLE 244 STEREOTAXIS, INC.: DEALS, JANUARY 2020–JUNE 2024
TABLE 245 B. BRAUN SE: COMPANY OVERVIEW
TABLE 246 B. BRAUN SE: PRODUCTS OFFERED
TABLE 247 ESAOTE SPA: COMPANY OVERVIEW
TABLE 248 ESAOTE SPA: PRODUCTS OFFERED
TABLE 249 ESAOTE SPA: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2024
TABLE 250 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
TABLE 251 SHIFAMED, LLC: COMPANY OVERVIEW
TABLE 252 CONAVI MEDICAL INC.: COMPANY OVERVIEW
TABLE 253 XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD.: COMPANY OVERVIEW
TABLE 254 BK MEDICAL: COMPANY OVERVIEW
TABLE 255 BENQ MEDICAL TECHNOLOGY: COMPANY OVERVIEW
TABLE 256 ECHONOUS INC.: COMPANY OVERVIEW
TABLE 257 VOLTA MEDICAL: COMPANY OVERVIEW
TABLE 258 TRIVITRON HEALTHCARE: COMPANY OVERVIEW
TABLE 259 ECHOPIXEL: COMPANY OVERVIEW
TABLE 260 CATHVISION: COMPANY OVERVIEW
TABLE 261 PIE MEDICAL IMAGING BV: COMPANY OVERVIEW
LIST OF FIGURES (56 FIGURES)
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4 INTRACARDIAC ECHOCARDIOGRAPHY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
FIGURE 5 INTRACARDIAC ECHOCARDIOGRAPHY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 GROWTH PROJECTIONS WERE BASED ON REVENUE IMPACT OF KEY MACROINDICATORS
FIGURE 9 INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 10 INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 11 INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY
FIGURE 13 INCREASING DEMAND FOR PREDICTIVE ANALYTICS IN ICE DEVICES—MAJOR FACTOR DRIVING INTRACARDIAC ECHOCARDIOGRAPHY INDUSTRY
FIGURE 14 ASIA PACIFIC REGIONAL MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 15 HOSPITALS & SURGICAL CENTERS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 17 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18 MARKET: PORTER’S FIVE FORCES MODEL
FIGURE 19 MARKET: ECOSYSTEM ANALYSIS
FIGURE 20 NUMBER OF DEALS IN MARKET, 2018–2022 (USD MILLION)
FIGURE 21 NUMBER OF INVESTOR DEALS IN MARKET, BY KEY PLAYER, 2018–2022
FIGURE 22 VALUE OF INVESTOR DEALS IN MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
FIGURE 23 MARKET: VALUE CHAIN ANALYSIS
FIGURE 24 MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 25 AVERAGE SELLING PRICE OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY PRODUCT (USD THOUSAND)
FIGURE 26 AVERAGE SELLING PRICE TREND OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY REGION, 2021–2023 (USD)
FIGURE 27 PATENT DETAILS FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, JANUARY 2013–DECEMBER 2023
FIGURE 28 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
FIGURE 29 MARKET: BUYING CRITERIA
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES
FIGURE 31 NORTH AMERICA: MARKET SNAPSHOT
FIGURE 32 ASIA PACIFIC: MARKET SNAPSHOT
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MARKET (2019–2023)
FIGURE 34 MARKET SHARE ANALYSIS (2023)
FIGURE 35 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS)
FIGURE 36 MARKET: COMPANY FOOTPRINT
FIGURE 37 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 38 EV/EBITDA OF KEY VENDORS
FIGURE 39 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 40 MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT (2023)
FIGURE 42 ABBOTT: COMPANY SNAPSHOT (2023)
FIGURE 43 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
FIGURE 45 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 46 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023)
FIGURE 47 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023)
FIGURE 48 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023)
FIGURE 49 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 50 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 51 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 52 GUERBET: COMPANY SNAPSHOT (2023)
FIGURE 53 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 54 LIVANOVA: COMPANY SNAPSHOT (2022)
FIGURE 55 STEREOTAXIS, INC.: COMPANY SNAPSHOT (2023)
FIGURE 56 B. BRAUN SE: COMPANY SNAPSHOT (2023)
Growth opportunities and latent adjacency in Intracardiac Echocardiography Market